Data443 Poised to Help Companies Accelerate GDPR Compliance

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
22
Data443 Poised to Help Companies Accelerate GDPR Compliance

RALEIGH, N.C., May 24, 2018 (GLOBE NEWSWIRE) -- With the European Union’s General Data Protection Regulation (GDPR) set to take effect tomorrow, Data443 Risk Mitigation, Inc., a leading data security company, today announced that its newly released rapid-implementation version of ClassiDocs™ (v1.36) can significantly fast-track GDPR compliance . ClassiDocs -- the company’s award-winning data classification , governance, and eDiscovery product -- now delivers significant improvements in explicit PII search and DSAR capabilities, which are core requirements of the GDPR. These solution benefits can be up and running quickly with Data443’s ability to deliver ClassiDocs via cloud and hybrid configurations.

“Data443 is ready for the large increase of client demand expected after the initiation of the GDPR,” said Jason Remillard, CEO and founder of Data443 Risk Mitigation, Inc. “Most organizations don’t realize that they can be GDPR compliant in a few hours with our product. This is a significant improvement over the months, and sometimes years, it takes other solutions to deploy.”

“The GDPR is just the beginning,” added Mr. Remillard. “The financial and brand risk implications of data privacy compliance are not being ignored, as witnessed by recent issues at Facebook and Google. We currently have dozens of company contracts out for bid, resulting in over $1M USD in potential recurring revenue streams. All of this incoming business was mainly in the tail end of the first quarter, and we continue to issue new quotations and initiate new PoC environments daily. The team is at full capacity and our first quarter investments are bearing fruit in both capability and market adoption.”

As more businesses understand the impact and potential liabilities of the GDPR, they are seeking solutions that can quickly move forward their ability to respond. ClassiDocs is purpose-built for privacy compliance enablement. The product directly addresses 12 of the most important GDPR articles, both for reporting and technical controls. This capability enables clients to respond to DSAR demands and at the same time provide an accurate and up-to-date data inventory across their entire data estate, including all end points, any attached or mapped cloud storage, databases, email, structured and unstructured data, and data at rest or in flight. ClassiDocs™ is the only product on the market with this wide-ranging, feature-rich capability set.

Upon deployment and without specific training, users can:

  • Discover PII, PCI, HIPAA, and Other Confidential Information
  • Report on and Remediate Security Access Controls
  • Respond to DSARs and Remediation Actions, with built in Analytics
  • Comply with 12 of the Most Critical GDPR Articles

Data443’s ability to quickly deliver ClassiDocs™ via cloud or hybrid configurations solves GDPR complexity for any organization currently facing the impending deadline without a compliance plan in place. Companies can start a PoC in minutes by clicking this link https://www.data443.com/get-free-online-inter...mo-team-2/ .

About DATA443 Risk Mitigation, Inc. DATA443 Risk Mitigation, Inc. (OTCPK:LDSR) enables secure data – across local devices, network, cloud, and databases – at rest and in flight. ClassiDocs™, our award-winning data classification and governance technology, supports over 200 file types and 400 databases with a user-first, user-centric design that speeds ease of use and compliance-policy conformance without training. Data443 delivers classification, discovery, governance, GDPR compliance, and DSAR management coupled with DLP, CASB, SIEM, and cloud solutions to provide user-enabled, governance-enabled, up-to-date security for every data point, every time. 

Forward-Looking Statements    Except for the historical information contained herein, the matters discussed in this press release are forward-looking statements. Actual results may differ materially from those described in forward-looking statements and are subject to risks and uncertainties. See DATA443 Risk Mitigation, Inc.’s filings with the SEC, which may identify specific factors that may cause actual results or events to differ materially from those described in the forward-looking statements.

For Further Information Follow us on Twitter: https://twitter.com/data443Risk Follow us on Facebook: https://www.facebook.com/data443/ Signup for our Investor Newsletter: https://www.data443.com/investor-relations/ Signup for our Product Newsletter: https://www.data443.com/contact/

Contacts

Main Press Contact: Susan Payne Susan.Payne@data443.com Office: 919.526.1070 Ext. 103

Investor Relations: ir@data443.com Office: 919.858.6542

SOURCE DATA443 Risk Mitigation, Inc.

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Lundbeck's Board Leadership Transitions into New Era

Updated Category News Views 15

A Fresh Chapter for Lundbeck's Board Leadership Lundbeck is sparking some fresh boardroom energy, and it's not just business as usual. Dorothea Wenzel, who's been steering the ship, is stepping down come 2027—AGM in sight. Now, in swings Lars Fruergaard Jørgensen, ready to grab the wheel. Yeah, we've got some seasoned pharma muscles flexing here. The Before and After:...

Continue Reading
AEVEX Faces 48-Hour Deadline for Investor Class Action

Updated Category News Views 23

Clock Ticking on AEVEX Lawsuit Participation Ah, the twists and turns of the stock market! AEVEX Corp. (NYSE: AVEX) finds itself knee-deep in a class action lawsuit, and investors have a mere 48 hours left to make their stand as the lead plaintiff. This legal saga stems from the company's April 2026 IPO and spills into the muddy waters of securities law violations....

Continue Reading
ASTS Faces a Legal Countdown – Investors Take Note

Updated Category News Views 28

AST SpaceMobile's Legal Tangle AST SpaceMobile, Inc. (NASDAQ:ASTS) finds itself neck-deep in legal quagmire, with a class action lawsuit looming large. Investors who snapped up ASTS securities between March 4, 2025, and July 15, 2026, have until November 13, 2026, to reckon their grievances before the courts. This is no joke, folks. If you've lost dough because of shaky...

Continue Reading
Faith and Resilience in China: The Legacy of the Long March

Updated Category News Views 34

History's got chapters that stick with you, and the Long March is one of those stories that shake you to your core. It all started one October evening in 1934, when more than 86,000 soldiers from the Red Army found themselves on the banks of the Yudu River. It was a scene straight out of a novel: 800-odd boats held together with coffin boards and timber beams, all set to...

Continue Reading
Antheia Secures $80M for Critical Medicine Onshoring

Updated Category News Views 26

Antheia's Bold Move to Onshore Medicine Production Folks, when it comes to pharmaceuticals, it's about time someone started serious about keeping things closer to home. Antheia just landed a huge $80 million conditional commitment from the U.S. Department of War's Office of Strategic Capital. The fine print? This isn't just about building business—it's a play to secure...

Continue Reading
Tomorrowland's Shanghai Return: An Electri-Lifesaver

Updated Category News Views 38

You know, every now and then, it's worth stepping out of the stock frenzy and diving into something as electrifying and far from the trading floor as Tomorrowland's latest Shanghai rendezvous. This ain't just any festival; it's the kind of hype that packs a punch—and frankly, it's a wild ride seeing such a spectacle set up shop in China, and sell out to boot. Partnering...

Continue Reading
UEG's New Advisory Board: Elevating Patient Voices

Updated Category News Views 33

Breaking Ground with Patient Representation Today's not-so-sunny forecast from Barcelona wasn't about the weather. United European Gastroenterology (UEG) rolled out its shiny new Patient Representatives Advisory Board (PRAB) during UEG Week 2026. This isn't just another committee on a never-ending list—it's a serious platform aimed at turning patient murmurs into a...

Continue Reading

Top 5 Most Recently Viewed Articles

Global Supply Chains Report 2025: Key Insights for Business Growth

Updated Category News Views 251

Introduction to the Global Supply Chains Report 2025 Supply Chain Digital, a prominent brand under BizClik, has recently unveiled its highly anticipated annual report, the Global Supply Chains Report 2025. This report aims to shed light on the organizations that are reshaping the landscape of global supply chains through innovation, sustainability, and resilience....

Continue Reading
Absci's Innovative Drug Pipeline and AI Breakthroughs Unveiled

Updated Category News Views 410

Innovative Developments at Absci's R&D Day Absci Corporation, renowned for its pioneering approach in drug creation using generative AI, recently highlighted its progress during a significant event focused on research and development. The company showcased its proprietary Drug Creation pipeline and advancements achieved through the AI Integrated Drug Creation™ platform....

Continue Reading
Exciting Developments in JAKKS Pacific's Financial Journey

Updated Category News Views 84

JAKKS Pacific to Announce Fourth Quarter and Year-End Results JAKKS Pacific, Inc. (NASDAQ: JAKK) is gearing up to share its financial performance for the fourth quarter and full year. The eagerly anticipated announcement will be made following the market close, drawing attention from analysts, investors, and the media alike. This event signifies not only the conclusion of...

Continue Reading
Crowley Enhances Logistics for Wreaths Across America Initiative

Updated Category News Views 153

Crowley Enhances Logistics for Wreaths Across America Initiative Crowley is taking significant steps to expand its logistical support for the Wreaths Across America program, reflecting its strong commitment to honoring U.S. military personnel. The company is facilitating this through financial sponsorship along with in-kind transportation and logistics services. Expanded...

Continue Reading
Unlocking the Wealth from Shopify: 15 Years of Growth Insights

Updated Category News Views 290

Shopify's Impressive Market Performance Over the past 15 years, Shopify (NASDAQ: SHOP) has consistently outperformed the market, boasting an impressive annualized return of 23.52%. This remarkable growth translates to a significant increase in wealth for those who invested in the company early on. At present, Shopify holds a market capitalization of $153.87 billion,...

Continue Reading